Head-to-head · Cost-Efficiency Index
Fitish vs eMI Aesthetics
Two GLP-1 programs on the bench, scored on the same six factors. Here's how their real cost of ownership compares — and which one we'd start with.
Fitish
Shoppers who want a genuinely all-in price with no separate consult fee, or a fixed low-dose 'microdose' option.
Visit FitisheMI Aesthetics
Shoppers wanting all-50-state compounded semaglutide or tirzepatide access with an AI progress simulator, willing to accept a price range rather than a fixed quote.
Visit eMI AestheticsThe verdict
Fitish and eMI Aesthetics tie on the Cost-Efficiency Index at 69/100, so neither wins outright on the numbers. For most shoppers we'd start with Fitish (ranked #92, a hair above #99) — Shoppers who want a genuinely all-in price with no separate consult fee, or a fixed low-dose 'microdose' option. But eMI Aesthetics is a genuine coin-flip alternative here.
Worth knowing either way: our overall #1 pick is CoreAge Rx (Cost-Efficiency Index 94/100 — the top of the ranking). See how it stacks up: CoreAge Rx vs Fitish.
Factor by factor
Both providers scored on our six Cost-Efficiency Index factors. The stronger side on each row is marked in teal.
Normalized Cost/Month
Price Transparency
Nationwide Access
Formulation Options
Clinical Oversight
Contract Flexibility
Pricing, coverage & formulary
The disclosed facts behind the scores. Lower price wins its row (teal).
| Spec | Fitish | eMI Aesthetics |
|---|---|---|
| Cost-Efficiency Index | 69/100 | 69/100 |
| Semaglutide / mo | $219/mo (microdose tier, plus a separate fee, compounded) | $179/mo (compounded) |
| Tirzepatide / mo | $339/mo (microdose tier, compounded) | $269/mo (compounded) |
| Semaglutide / yr (modeled) | $2,628 | $2,148 |
| Tirzepatide / yr (modeled) | $4,068 | $3,228 |
| Coverage | All 50 states | All 50 states |
| Oral / sublingual | Yes | Yes |
| Brand-name access | Yes | Yes |
| Rank here | #92 | #99 |
Fitish
69/100Where the value is
- Price genuinely includes consult, medication, and shipping — confirmed in the product page's own text, not just marketing copy
- A real microdose tier exists at a meaningfully lower fixed price for both drugs
- Injectable and oral tablet formats both offered
The tradeoffs
- No stated minimum commitment or cancellation terms found on the product pages
- No named prescriber, medical director, or specific compounding pharmacy
Regulatory note: the FDA issued a warning letter to FITISH in June 2026. We still list and link to Fitish; you should know the letter is on the public record before you decide.
eMI Aesthetics
69/100Where the value is
- Available to eligible patients in all 50 U.S. states per the site's own GLP-1 program page
- Offers semaglutide in both injectable and oral form, plus tirzepatide, on one platform
- Full program cost is bundled — evaluation, medication, delivery, coaching, and follow-up with no separate fees itemized
The tradeoffs
- The advertised '$179/month' is the FLOOR of a $179-$249 range for the injection alone; oral semaglutide runs $209-$279 and tirzepatide $269-$339 — the actual price a patient pays isn't disclosed before intake
- No specific dispensing pharmacy is named
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Cost-Efficiency Index. Pricing, states and verification reflect each provider's public disclosures at last review; prices change — confirm on the provider's site. Not medical advice. See our disclosure.